Enfusion, Inc (ENFN) Reports In-Line Q3 EPS; Offers FY22 Revenue Guidance

Enfusion, Inc (NYSE: ENFN) reported Q3 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $39.2 million versus the consensus estimate of $38.59 million.

GUIDANCE:

Enfusion, Inc sees FY2022 revenue of $149.3-150.3 million, versus the consensus of $150.7 million.

For earnings history and earnings-related data on Enfusion, Inc (ENFN) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• Autodesk (ADSK) Tops Q2 EPS by 18c, Beats on Revenue; Offers FY27 EPS Guidance
• PagerDuty, Inc. (PD) Tops Q2 EPS by 1c; offers guidance